Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited)

v3.10.0.1
Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 17,502 $ 4 $ 128,549,458 $ (169,180,425) $ (40,613,461)
Balance, shares at Dec. 31, 2017 1,750,275 39,502      
Conversion of Series H Preferred stock into common stock $ 4 (4)
Conversion of Series H Preferred stock into common stock, shares (50) 40,000      
Common stock issued in cashless exercise of warrants $ 150 4,619,000 $ 4,619,150
Common stock issued in cashless exercise of warrants, shares 1,492,228     286,240,000
Common stock issued for conversion of Series I-2 Preferred stock $ 176 632,924 $ 633,100
Common stock issued for conversion of Series I-2 Preferred stock, shares 1,764,927   633,100
Conversion of debentures into common stock $ 389 8,084,953 $ 8,085,342
Conversion of debentures into common stock, shares 3,886,680      
Exchange of notes payable and accrued expenses for Series J Preferred Stock $ 2,500 247,500 250,000
Exchange of notes payable and accrued expenses for Series J Preferred Stock, shares 250,000      
Stock-based compensation 261,796 261,796
Deemed dividend from trigger of down round provision feature 17,942,579 (17,942,579)
Exchange of debentures into Series I-2 Preferred stock 1,420 1,420
Restricted stock issued to employees $ 14 477,919 477,933
Restricted stock issued to employees, shares 142,667      
Adjustment to treasury shares $ (122)
Adjustment to treasury shares, shares      
Net loss (3,850,010) (3,850,011)
Balance at Sep. 30, 2018 $ 20,002 $ 737 $ 160,817,545 $ (190,973,014) $ (30,134,730)
Balance, shares at Sep. 30, 2018 2,000,225 7,365,881